Daniel Devine & Co »

SPDR S&P Biotech shares owned by Daniel Devine & Co

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Daniel Devine & Co from 13F filings

Historical chart of Daniel Devine & Co investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Daniel Devine & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Daniel Devine & Co

Quarter filed Position value Share count Share price at filing
2018-06-30 $704k 7.4k 95.14
2018-03-31 $553k 6.3k 87.78

More positions owned by Daniel Devine & Co

Spdr S&p 500 Etf (SPY)
PowerShares QQQ Trust, Series 1
SPDR S&P MidCap 400 ETF (MDY)
Apple (AAPL)
iShares NASDAQ Biotechnology Index (IBB)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc. Class B
Visa (V)
Abbvie (ABBV)
Chevron Corporation (CVX)
iShares MSCI Emerging Markets Indx (EEM)
UnitedHealth (UNH)
Honeywell International (HON)
Pfizer (PFE)
Costco Wholesale Corporation (COST)

View all positions for Daniel Devine & Co

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech